A new Report by Delvens, titled "Artificial Intelligence (AI) in Medical Diagnostics Market” offers a comprehensive analysis of the industry, which comprises insights on the Global analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The global Artificial Intelligence (AI) in Medical Diagnostics Market size is expected to reach USD 12.2 billion and is projected to reach a CAGR of 33.9% from 2023-2030.
Get Free Sample Report: https://www.delvens.com/get-free-sample/artificial-intelligence-in-medical-diagnostics-market
The use of AI technologies and algorithms in the area of medical diagnostics is referred to as artificial intelligence (AI) in the medical diagnostics market. By facilitating more precise and effective medical image processing, data interpretation, and decision-making, AI has the potential to revolutionize medical diagnostics.
In recent years, the market for AI in medical diagnostics has grown significantly. Large medical datasets are becoming more widely available, medical imaging methods are being used more often, and AI algorithms are all contributing to this rise. AI may help medical personnel identify, diagnose, and keep track of a wide range of illnesses and problems, such as cancer, cardiovascular issues, neurological disorders, and more.
Delvens Industry Expert's Standpoint
The AI in the Medical Diagnostics market is a vibrant and quickly developing sector of the economy. The market may be described as being both fragmented and consolidated. While there are many different participants, including startups, research institutes, and specialized AI solution providers, existing healthcare organizations and large technology firms also play a vital role. The rising availability of medical data, improvements in machine learning and deep learning techniques, and the expanding need for quicker and more accurate diagnosis are some of the reasons driving the market.
Competitive Landscape
- IBM Corporation
- Google LLC (Alphabet Inc.)
- Microsoft Corporation
- NVIDIA Corporation
- General Electric Company (GE Healthcare)
- Siemens Healthineers AG
- Aidoc Medical Ltd.
- Butterfly Network Inc.
- Zebra Medical Vision Ltd.
- AliveCor Inc.
- Intel Corporation
- Digital Diagnostics, Inc.
- Xilinx
- InformAI LLC
- HeartFlow, Inc.
- Enlitic, Inc.
- Day Zero Diagnostics, Inc.
- Aidence
- Prognos Health
- Nanox AI
- ai, Inc.
- Quibin
- ai
- Therapixel
- Koninklijke Philips N.V.
- Inc.
- EchoNous Inc.
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/artificial-intelligence-in-medical-diagnostics-market
Key Findings:
The application segment is further segmented into Radiology, pathology, cardiology, oncology, neurology, and others. The application of AI in radiology has gained substantial attention and investment.
The technology segment is further fragmented into Machine Learning, Natural Language Processing (NLP), Computer Vision, and Expert Systems.
The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. These regions have been at the forefront of AI adoption in medical diagnostics.
Recent Developments
- In June 2021, The American College of Cardiology (ACC) and GE Healthcare are working together to create a roadmap for digital technology and artificial intelligence (AI) in cardiology as well as novel approaches for bettering patient outcomes.
- In June 2021, By acquiring CardioLabs, AliveCor creates the foundation for the introduction of Advanced Ambulatory Monitoring Services.
Access Full Report: https://www.delvens.com/report/artificial-intelligence-in-medical-diagnostics-market
In addition to the market data for Artificial Intelligence (AI) in Medical Diagnostics Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements.
Reasons to Acquire
- Increase your understanding of the market for identifying the most suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors.
- Gain authentic and granular data access for the Relapsed/Refractory Multiple Myeloma (RRMM) Market to understand the trends and the factors involved in changing market situations.
- Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.
Browse More Reports from Delvens:
Assisted Living (AL) market size was estimated at USD 180.70 billion in 2023 and is projected to reach USD 305.70 billion in 2030 at a CAGR of 7.8% during the forecast period 2023-2030.
Congenital Heart Disease (CHD) market size was estimated at USD 4.47 billion in 2023 and is projected to reach USD 8.11 billion in 2030 at a CAGR of 8.87% during the forecast period 2023-2030.
Periodontal Disease Treatment market size was estimated at USD 799.17 million in 2023 and is projected to reach USD 1438.54 million in 2030 at a CAGR of 8.76% during the forecast period 2023-2030.
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT Telecom, Chemicals Materials, Semiconductor Electronics, Energy, Pharmaceutical, Consumer Goods Services, Food Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-3290-6466
+1 214-377-1144
